David CAMPBELL
10Patents
3h-index
11Co-inventors
57Inventor score
Filing activity: Apr 3, 1984 → May 4, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4693893A | Vaccines for equine influenza | Chemistry; Metallurgy | 27 | Expired |
| US6045790A | Vaccines for equine influenza | Chemistry; Metallurgy | 9 | Expired |
| US9309285B2 | Macrocyclic broad spectrum antibiotics | Emerging Cross-Sectional Technologies | 5 | Active |
| US10501493B2 | Broad spectrum antibiotics | Emerging Cross-Sectional Technologies | 2 | Active |
| US8999922B2 | Linear peptide antibiotics | Emerging Cross-Sectional Technologies | 1 | Active |
| US11512113B2 | Cleavable linker compositions and methods | Chemistry; Metallurgy | 1 | Active |
| US12161724B2 | Compositions and methods related to tumor activated antibodies targeting EGFR and effector cell antigens | Chemistry; Metallurgy | 0 | Active |
| US9726667B2 | Point of care assays to detect the status of tuberculosis infection | Physics | 0 | Active |
| US11555078B2 | Compositions and methods related to tumor activated antibodies targeting PSMA and effector cell antigens | Chemistry; Metallurgy | 0 | Active |
| US9708368B2 | Linear peptide antibiotics | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.